Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
CDKL5 Deficiency Disorder
.
Show all posts
Showing posts with label
CDKL5 Deficiency Disorder
.
Show all posts
Wednesday, May 4, 2022
FDA Approves Ztalmy (ganaxolone) for Seizures Associated with CDKL5 Deficiency Disorder
›
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seiz...
Monday, January 3, 2022
Marinus Announces FDA Acceptance for New Drug Application for Ganaxolone in CDKL5 Deficiency Disorder
›
Marinus Pharmaceuticals, Inc. announced the U.S. FDA acceptance for filing the company’s New Drug Application (NDA) for the use o...
›
Home
View web version
